11 de January de 1842
- Kasznar Leonardos
Life Sciences
Our Life Sciences team is highly familiar with the industry and is greatly experienced in the field, standing at the forefront of pioneering and multidisciplinary cases.
We are able to act in a thorough fashion across questions of the most varied natures, since we rely on the consultancy of a team of professionals that are highly skilled in multiple fields of legal nature in addition to other specialists such as engineers, medical doctors, pharmaceutical experts, biomedical researchers, biologists, chemical engineers, among others.
Our clients’ portfolio comprises domestic and transnational companies acting in the fields of health, medicaments, biological products, pharmaceutical actives, medical devices and health techs, in addition to the fields of cosmetics, foodstuffs and agrochemical products.
You may rely on our assistance to create solutions aimed at customizing and specifically fulfilling the requirements of your company, such as for example:
Last related news
19 de August de 2026
Brazilian PTO Publishes 2027–2036 Strategic Plan: What It Means for Users of Brazil’s IP System
Brazil’s National Institute of Industrial Property (INPI) released its new Strategic Plan for 2027–2036 on August 14, 2026. The plan launches a … Brazilian PTO Publishes 2027–2036 Strategic Plan: What It Means for Users of Brazil’s IP System
14 de August de 2026
INPI and INDECOPI Launch Collaborative Patent Examination Project Focusing on Pharmaceuticals and Biotechnology
On August 11, 2026, the Brazilian Patent and Trademark Office (INPI) announced the launch of the Collaborative Patent Application Examination Project, developed … INPI and INDECOPI Launch Collaborative Patent Examination Project Focusing on Pharmaceuticals and Biotechnology
13 de August de 2026
Viviane Trojan has been ranked by IAM Strategy 300
We are honored to announce that our partner Viviane Trojan has been ranked in the IAM Strategy 300, earning recognition in the categories … Viviane Trojan has been ranked by IAM Strategy 300